PharmaLegacy Laboratories (Shanghai) Co., Ltdis a DMPKx2a38631n,Non-Human Primates modelsin one large multi-functional integrated modern enterprise,and devote the high-quality Syngeneic mouse model and first-class service for the masses of customers.

   PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Patient-derived tumor xenograft mouse models (PDX Model) are a versatile oncology research platform for studying tumor biology and for testing chemotherapeutic approaches tailored to genomic characteristics of individual patient's tumors. PDX models are typically implanted as dissociated cells or tumor fragments into immune-deficient mouse models which may then be used for in vivo efficacy studies, allowing you to accelerate your oncology research or drug discovery and development programs. PDX models are generated and distributed by a diverse group of academic labs, research organizations, multi-institution consortia, and contract research organizations. To better preserve the genomic integrity and tumor heterogeneity observed in patients, patient-derived xenograft (PDX) models were generated using freshly resected patient tumors immediately transplanted into immunocompromised murine hosts without an intermediate in vitro culture step. Pharmalegacy has patient information with diagnosis and treatment history, with 367 PDX models covering 6 cancer types and more ongoing. Pharmalegacy has well established PDX model and ready for cancer therapeutics evaluation.

   Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacySyngeneic mouse model, please visit our official website: www.pharmalegacy.com.